Cargando…

Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy

Although breast density decline with tamoxifen therapy is associated with greater therapeutic benefit, limited data suggest that endocrine symptoms may also be associated with improved breast cancer outcomes. However, it is unknown whether endocrine symptoms are associated with reductions in breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramin, Cody, Pfeiffer, Ruth M., Fan, Sharon, Mullooly, Maeve, Falk, Roni T., Jones, Kristine, Caporaso, Neil E., Bey-Knight, Lisa, Sak, Mark A., Simon, Michael S., Gorski, David H., Ali, Haythem, Littrup, Peter, Duric, Neb, Sherman, Mark E., Gierach, Gretchen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017770/ https://www.ncbi.nlm.nih.gov/pubmed/36922547 http://dx.doi.org/10.1038/s41523-023-00511-8

Ejemplares similares

Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography
por: Gierach, Gretchen L., et al.
Publicado: (2022)

Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed
por: Duric, Neb, et al.
Publicado: (2020)

Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients
por: Mullooly, Maeve, et al.
Publicado: (2019)

The Potential Role of the Fat–Glandular Interface (FGI) in Breast Carcinogenesis: Results from an Ultrasound Tomography (UST) Study
por: Duric, Nebojsa, et al.
Publicado: (2021)

Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort
por: Wang, Shao-Ming, et al.
Publicado: (2020)

Relationship of circulating insulin-like growth factor-I and binding proteins 1–7 with mammographic density among women undergoing image-guided diagnostic breast biopsy
por: Hada, Manila, et al.
Publicado: (2019)

Mammographic Breast Density and Breast Cancer Molecular Subtypes: The Kenyan-African Aspect
por: Shaikh, Asim Jamal, et al.
Publicado: (2018)

Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients
por: Mullooly, Maeve, et al.
Publicado: (2017)

Erratum to “Automatic Segmentation of Ultrasound Tomography Image”
por: Wu, Shibin, et al.
Publicado: (2017)

Efficient Segmentation of a Breast in B-Mode Ultrasound Tomography Using Three-Dimensional GrabCut (GC3D)
por: Yu, Shaode, et al.
Publicado: (2017)

Automatic Segmentation of Ultrasound Tomography Image
por: Wu, Shibin, et al.
Publicado: (2017)

Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy
por: Bodelon, Clara, et al.
Publicado: (2021)

Multicenter Study of Whole Breast Stiffness Imaging by Ultrasound Tomography (SoftVue) for Characterization of Breast Tissues and Masses
por: Littrup, Peter J., et al.
Publicado: (2021)

Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016
por: Ramin, Cody, et al.
Publicado: (2021)

Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients
por: Sherman, Mark E., et al.
Publicado: (2016)

Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study
por: Falk, Roni T, et al.
Publicado: (2013)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
por: Klinge, Carolyn M.
Publicado: (2015)

Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy
por: Hada, Manila, et al.
Publicado: (2020)

A novel algorithm to reduce VTE in peri-operative patients on tamoxifen()()()
por: Nicola, Alexi, et al.
Publicado: (2021)

Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density
por: Mullooly, Maeve, et al.
Publicado: (2019)

Model-based optical and acoustical compensation for photoacoustic tomography of heterogeneous mediums
por: Pattyn, Alexander, et al.
Publicado: (2021)

Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line
por: Won, Hye Sung, et al.
Publicado: (2016)

Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients
por: Lima, Mariana Tavares Miranda, et al.
Publicado: (2017)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.
por: Lissoni, P., et al.
Publicado: (1995)

Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Smith, Amelia, et al.
Publicado: (2018)

Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer Cells
por: Candelaria, Nicholes R., et al.
Publicado: (2015)

The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
por: Buijs, S.M., et al.
Publicado: (2023)

Long-Term Tamoxifen Effects in the Cyclic Interaction of the Endocannabinoid and Endocrine System in the Rat Central Nervous System
por: Fonseca, Bruno M., et al.
Publicado: (2023)

ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy
por: Wang, Jing, et al.
Publicado: (2023)

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
por: Uchino, J., et al.
Publicado: (1994)

Risk factors for breast cancer development by tumor characteristics among women with benign breast disease
por: Figueroa, Jonine D., et al.
Publicado: (2021)

Valproate utilisation trends among women of childbearing potential in Ireland between 2014 and 2019: A drug utilisation study using interrupted time series
por: Hughes, John E., et al.
Publicado: (2022)

Tamoxifen activity against Plasmodium in vitro and in mice
por: Weinstock, Ada, et al.
Publicado: (2019)

Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant)
por: Chan, Carmen Wing Han, et al.
Publicado: (2020)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Løkkegaard, Sanne, et al.
Publicado: (2021)

Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
por: Trialists' Group, The ATAC
Publicado: (2001)

Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study
por: Bennett, Kathleen E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hhiq37fnqm9veh050474ruh2lo